| Pritesh Harish Gandhi, MD, MPH | |
|
1101 Camino La Costa, Austin, TX 78752-3930 | |
| (512) 684-1832 | |
| Not Available |
| Full Name | Pritesh Harish Gandhi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1101 Camino La Costa, Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003115452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | Q3364 (Texas) | Primary |
| 208000000X | Pediatrics | Q3364 (Texas) | Secondary |
| Entity Name | Peoples Community Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598896391 PECOS PAC ID: 1951337237 Enrollment ID: O20050711000111 |
News Archive
According to the Academy of Medical Sciences, a new body to regulate all health research in the UK should be established. The authorities suggest that the current regulatory system was dysfunctional and thus hampering medical advances and they blame red tape for the decline in the UK's share of clinical research. The report suggests creating a Health Research Agency that would make approving projects quicker and cheaper. According to Health Secretary for England, Andrew Lansley, the government would consider how the recommendations could be implemented.
In an Aug. 7 letter to Texas Health and Human Services Executive Commissioner Albert Hawkins, CMS official Dianne Heffron questioned whether the state's plan to overhaul Medicaid by providing subsidized health coverage to 2.1 million uninsured residents would move quickly enough and be broad enough to justify relaxing federal rules, the Dallas Morning News reports. Heffron wrote, "It appears that significant, comprehensive reform would not begin until September 2010."
For years, scientists have noticed a particular oral bacterium can be found in the amniotic fluid of about 20 percent of women with premature babies.
The board directing the troubled Oregon health exchange is meeting this week to begin making recommendations about next steps and the future. In addition, Washington's health benefit exchange faces challenges of its own.
Alder Biopharmaceuticals Inc. today announced that data from a Phase 2 study of its ALD518 investigational antibody therapeutic that targets interleukin-6 (IL-6) demonstrate a reversal of anemia in patients with advanced non-small cell lung cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pritesh Harish Gandhi, MD, MPH 1101 Camino La Costa, Austin, TX 78752-3930 Ph: (512) 684-1832 | Pritesh Harish Gandhi, MD, MPH 1101 Camino La Costa, Austin, TX 78752-3930 Ph: (512) 684-1832 |
News Archive
According to the Academy of Medical Sciences, a new body to regulate all health research in the UK should be established. The authorities suggest that the current regulatory system was dysfunctional and thus hampering medical advances and they blame red tape for the decline in the UK's share of clinical research. The report suggests creating a Health Research Agency that would make approving projects quicker and cheaper. According to Health Secretary for England, Andrew Lansley, the government would consider how the recommendations could be implemented.
In an Aug. 7 letter to Texas Health and Human Services Executive Commissioner Albert Hawkins, CMS official Dianne Heffron questioned whether the state's plan to overhaul Medicaid by providing subsidized health coverage to 2.1 million uninsured residents would move quickly enough and be broad enough to justify relaxing federal rules, the Dallas Morning News reports. Heffron wrote, "It appears that significant, comprehensive reform would not begin until September 2010."
For years, scientists have noticed a particular oral bacterium can be found in the amniotic fluid of about 20 percent of women with premature babies.
The board directing the troubled Oregon health exchange is meeting this week to begin making recommendations about next steps and the future. In addition, Washington's health benefit exchange faces challenges of its own.
Alder Biopharmaceuticals Inc. today announced that data from a Phase 2 study of its ALD518 investigational antibody therapeutic that targets interleukin-6 (IL-6) demonstrate a reversal of anemia in patients with advanced non-small cell lung cancer.
› Verified 5 days ago
Dr. Tatiana B. Jacobson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Caves Rd. Bldg C Ste. 102, Austin, TX 78746 Phone: 512-323-5465 Fax: 512-327-1390 | |
Preeti Venkatraman, M.B.B.S. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E 15th St, Austin, TX 78701 Phone: 512-324-7000 | |
Dr. Joshua Lane Davis, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1004 W 32nd St Unit 300, Austin, TX 78705 Phone: 512-324-3440 | |
Dr. Analicia Alvarado, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Red River St, Austin, TX 78701 Phone: 512-324-7000 | |
Dr. Grace Marie Grant-jennings, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7000 North Mopac, Suite # 420, Austin, TX 78731 Phone: 512-482-0045 Fax: 512-476-9892 | |
Dr. Debra Ann Patt, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6204 Balcones Dr, Austin, TX 78731 Phone: 512-427-9400 Fax: 512-342-2723 |